Concepedia

Author

Inge Tinhofer

Charité - Universitätsmedizin Berlin

Also Known As

Inge Tinhofer

106

Publications

3.1K

Citations

30

H-Index

57

Concepts

All Affiliations

Charité - Universitätsmedizin BerlinHeidelberg UniversityGerman Cancer Research CenterHelmholtz-Zentrum Dresden-RossendorfTechnical University of Munich
IT

About

Inge Tinhofer is an author at Charité - Universitätsmedizin Berlin specializing in medicine, cell biology, and immunology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

15

15

915

2

Cell Biology

9

9

451

3

Health Sciences

3

3

188

4

Cellular Physiology

3

3

108

5

Natural Sciences

1

1

50

Inge Tinhofer

×

37

Publications

2.8K

Citations

30

H-Index

YearCitations

A comparative study of machine learning methods for time-to-event survival data for radiomics risk modelling

Stefan Leger, Alex Zwanenburg, K. Pilz,

Scientific Reports

2017

222

Critical Role of Calcium- dependent Epidermal Growth Factor Receptor Transactivation in PC12 Cell Membrane Depolarization and Bradykinin Signaling

Esther Zwick, Henrik Daub, Naohito Aoki,

Journal of Biological Chemistry

1997

203

CD8+ tumour-infiltrating lymphocytes in relation to HPV status and clinical outcome in patients with head and neck cancer after postoperative chemoradiotherapy: A multicentre study of the German cancer consortium radiation oncology group (DKTK-ROG)

Panagiotis Balermpas, Franz Rödel, Claus Rödel,

International Journal of Cancer

2015

202

Resveratrol, a tumor‐suppressive compound from grapes, induces apoptosis via a novel mitochondrial pathway controlled by Bcl‐2

Inge Tinhofer, David Bernhard, Monika Senfter,

The FASEB Journal

2001

182

HPV16 DNA status is a strong prognosticator of loco-regional control after postoperative radiochemotherapy of locally advanced oropharyngeal carcinoma: Results from a multicentre explorative study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG)

Fabian Lohaus, Annett Linge, Inge Tinhofer,

Radiotherapy and Oncology

2014

145

Enhanced MTT-reducing activity under growth inhibition by resveratrol in CEM-C7H2 lymphocytic leukemia cells

David Bernhard, Wolfgang Schwaiger, Roman Crazzolara,

Cancer Letters

2003

137

HPV status, cancer stem cell marker expression, hypoxia gene signatures and tumour volume identify good prognosis subgroups in patients with HNSCC after primary radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG)

Annett Linge, Fabian Lohaus, Steffen Löck,

Radiotherapy and Oncology

2016

135

Expression of functional interleukin-15 receptor and autocrine production of interleukin-15 as mechanisms of tumor propagation in multiple myeloma

Inge Tinhofer, I Marschitz, Traudl Henn,

Blood

2000

132

Low Cancer Stem Cell Marker Expression and Low Hypoxia Identify Good Prognosis Subgroups in HPV(−) HNSCC after Postoperative Radiochemotherapy: A Multicenter Study of the DKTK-ROG

Annett Linge, Steffen Löck, Volker Gudziol,

Clinical Cancer Research

2016

130

Differential Sensitivity of CD4+ and CD8+T Lymphocytes to the Killing Efficacy of Fas (Apo-1/CD95) Ligand+ Tumor Cells in B Chronic Lymphocytic Leukemia

Inge Tinhofer, I Marschitz, Marion Kos,

Blood

1998

107

Page 1